SMC
AGN

Smith, Moore & Co’s Allergan plc AGN Stock Holding History

Smith, Moore & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,679
Closed -$224K – 351
2018
Q4 		$224K Sell
1,679
-566
-25% -$92.8K 0.06% 276
2018
Q3 		$428K Buy
2,245
+433
+24% +$79.5K 0.1% 197
2018
Q2 		$302K Buy
1,812
+169
+10% +$27.1K 0.08% 239
2018
Q1 		$276K Sell
1,643
-349
-18% -$58.5K 0.07% 241
2017
Q4 		$326K Buy
1,992
+213
+12% +$38.2K 0.09% 212
2017
Q3 		$365K Buy
+1,779
New +$414K 0.1% 198

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Smith, Moore & Co's AGN Position: Q1 2019 in Review

Smith, Moore & Co sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 1,679 shares — an estimated $224K sold.

Smith, Moore & Co first reported a position in AGN in Q3 2017 and held it in 6 quarters. The position peaked at $428K in Q3 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Smith, Moore & Co reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Smith, Moore & Co sold 1,679 Allergan plc shares in Q1 2019, an estimated $224K.
  • Smith, Moore & Co first reported a position in Allergan plc in Q3 2017 and held it in 6 quarters.
  • Smith, Moore & Co's Allergan plc position peaked at $428K in Q3 2018.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Smith, Moore & Co's 13F filing for Q1 2019, filed 7 May 2019.